Article info

Original research
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity

Authors

  1. Correspondence to Dr Maria Jure-Kunkel; mjk{at}genmab.com
View Full Text

Citation

Muik A, Adams HC, Gieseke F, et al
DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity

Publication history

  • Accepted April 26, 2022
  • First published June 10, 2022.
Online issue publication 
January 24, 2024
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.